Private Equity, VC & Investor
Gimv vs Sofina
Structured technology and market comparison · 2026
Direct Feature Comparison
Gimv · vs · SofinaListed European private equity investor backing growth companies.
Listed investment company providing patient capital to private growth businesses.
Analyze all overlapping signals and tech stacks for Gimv and Sofina
Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.
Comparison Analysis
What is the main difference between Gimv and Sofina?
When comparing Gimv and Sofina, both platforms operate within the Private Equity, VC & Investor ecosystem. Gimv is positioned as Listed European private equity investor backing growth companies, whereas Sofina focuses on Listed investment company providing patient capital to private growth businesses. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.
What are the top alternatives to Gimv and Sofina?
When evaluating Gimv and Sofina, enterprise buyers also consider other platforms in Private Equity, VC & Investor. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
How do the corporate scale, structure, and headquarters of Gimv and Sofina compare?
Gimv is headquartered in Belgium (founded in 1980) with 50–200 employees. Sofina is based in Belgium (founded in 1898) with 50–200 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.
Market Signals
Recent Market Signals & Activity: Gimv vs Sofina
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
Gimv
Recent Signals
- ·Gimv
Gimv successfully completes private placement of a bond for an amount of EUR 150 million
Gimv has successfully completed a private placement of a bond for EUR 150 million, as announced on 24/09/2026.
- ·Gimv
Excellent portfolio performance leads to a 7.5% increase in Net Asset Value to EUR 57.2 per share
Gimv reports a 7.5% increase in Net Asset Value to EUR 57.2 per share, driven by excellent portfolio performance. Additionally, portfolio companies Biotalys secured product registration in California for EVOCA®, and Onera's STS 2 falls within the scope of the EU MDR certificate.
Sofina
Recent Signals
No recent market signals documented for Sofina in the current tracking window.
Compare their exact ecosystem overlaps.
Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners Gimv and Sofina share across the market ecosystem.
Unlock full capability matrix, client overlaps & technology stacks